Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (281-290 of 334) with videos related to

Pageof 34
Sort By:
Blood Advances|April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHDZachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Nature|July 19, 2019
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasionAnna M Paczulla, Kathrin Rothfelder, Simon Raffel, et al.
The Journal of Experimental Medicine|August 28, 2013
The Nlrp3 inflammasome regulates acute graft-versus-host diseaseDragana Jankovic, Jayanthi Ganesan, Michael Bscheider, et al.
Blood Advances|August 28, 2023
GPRC5C drives branched-chain amino acid metabolism in leukemogenesisYu Wei Zhang, Talia Velasco-Hernandez, Julian Mess, et al.
Blood|June 17, 2020
Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humansJohana Norona, Petya Apostolova, Dominik Schmidt, et al.
Nature Immunology|December 20, 2024
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1<sup>+</sup>CD8<sup>+</sup> T cellsZhen Zhang, Marlene Langenbach, Sagar Sagar, et al.
Nature Medicine|May 20, 2014
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damageLukas Schwab, Luise Goroncy, Senthilnathan Palaniyandi, et al.
Nature Communications|April 5, 2020
Oncogenic Kras<sup>G12D</sup> causes myeloproliferation via NLRP3 inflammasome activationShaima'a Hamarsheh, Lena Osswald, Benedikt S Saller, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Fever supports CD8<sup>+</sup> effector T cell responses by promoting mitochondrial translationDavid O'Sullivan, Michal A Stanczak, Matteo Villa, et al.
Bone Marrow Transplantation|April 10, 2026
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMTAlexandros Kanellopoulos, Linda Koster, Hugues de Lavallade, et al.
Pageof 34

Showing results (281-290 of 334) with videos related to

Sort By:
Pageof 34
Blood Advances|April 19, 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHDZachariah DeFilipp, Haesook T Kim, Nikolaos Spyrou, et al.
Nature|July 19, 2019
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasionAnna M Paczulla, Kathrin Rothfelder, Simon Raffel, et al.
The Journal of Experimental Medicine|August 28, 2013
The Nlrp3 inflammasome regulates acute graft-versus-host diseaseDragana Jankovic, Jayanthi Ganesan, Michael Bscheider, et al.
Blood Advances|August 28, 2023
GPRC5C drives branched-chain amino acid metabolism in leukemogenesisYu Wei Zhang, Talia Velasco-Hernandez, Julian Mess, et al.
Blood|June 17, 2020
Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humansJohana Norona, Petya Apostolova, Dominik Schmidt, et al.
Nature Immunology|December 20, 2024
Efficacy of CTLA-4 checkpoint therapy is dependent on IL-21 signaling to mediate cytotoxic reprogramming of PD-1<sup>+</sup>CD8<sup>+</sup> T cellsZhen Zhang, Marlene Langenbach, Sagar Sagar, et al.
Nature Medicine|May 20, 2014
Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damageLukas Schwab, Luise Goroncy, Senthilnathan Palaniyandi, et al.
Nature Communications|April 5, 2020
Oncogenic Kras<sup>G12D</sup> causes myeloproliferation via NLRP3 inflammasome activationShaima'a Hamarsheh, Lena Osswald, Benedikt S Saller, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Fever supports CD8<sup>+</sup> effector T cell responses by promoting mitochondrial translationDavid O'Sullivan, Michal A Stanczak, Matteo Villa, et al.
Bone Marrow Transplantation|April 10, 2026
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMTAlexandros Kanellopoulos, Linda Koster, Hugues de Lavallade, et al.
Pageof 34